$0.0200
0.004125.79%
At close: Jan 15, 4:00 PM EST
$0.0239
0.00850.31%
Pre-Market: 3:00 AM EST
Comments
Loading...
Dermata Therapeutics (DRMAW) Stock Price, Quote, News & History
DRMAWNASDAQ
Edge Rankings
Stock Score Locked: Want to See it?
Benzinga Rankings give you vital metrics on any stock – anytime.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Dermata Therapeutics (DRMAW) stock?
You can purchase shares of Dermata Therapeutics (NASDAQ:DRMAW) through any online brokerage.
Who are Dermata Therapeutics (DRMAW) competitors?
Other companies in Dermata Therapeutics’s space includes: Estrella Immunopharma Inc (NASDAQ:ESLAW), Ainos Inc (NASDAQ:AIMDW), BriaCell Therapeutics Corp (NASDAQ:BCTXW), BriaCell Therapeutics Corp (NASDAQ:BCTXZ) and Medicus Pharma Ltd (NASDAQ:MDCXW).
What is the forecast, or price target, for Dermata Therapeutics (DRMAW) stock?
There is no analysis for Dermata Therapeutics to provide a consensus price target.
What is the current price for Dermata Therapeutics (DRMAW)?
The stock price for Dermata Therapeutics (NASDAQ: DRMAW) is $0.0239 last updated January 8, 2026 at 8:10 AM EST.
Does Dermata Therapeutics (DRMAW) pay a dividend?
There are no upcoming dividends for Dermata Therapeutics.
When is Dermata Therapeutics (NASDAQ:DRMAW) reporting earnings?
Dermata Therapeutics does not have any upcoming earnings scheduled.
Is Dermata Therapeutics (DRMAW) going to split?
There is no upcoming split for Dermata Therapeutics.
What sector and industry does Dermata Therapeutics (DRMAW) operate in?
Dermata Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
